PDCD1 and non-small cell lung carcinoma: Additionally, one retrospective study examined combined effect of argon–helium cryoablation and monoclonal anti-PD-1 antibody nivolumab immunotherapy in patients with stage IIIb-IV NSCLC, who had a relapse after radiotherapy, surgical resection or radical radiotherapy, or disease progression after chemotherapy [17].